Is it time to buy a2 Milk Company Ltd (Australia) shares?

The a2 Milk Company Ltd (Australia) (ASX:A2M) share price has climbed 4% higher today. Should you be buying as well?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite the market sinking lower for a fourth day in a row, the a2 Milk Company Ltd (Australia) (ASX: A2M) share price has managed to push higher.

At the time of writing the dairy company's shares are 4% higher at $7.10.

Is it time to buy a2 Milk shares?

Judging by the market reaction today, many investors appear to believe that a2 Milk's shares are good value again following its sharp decline over the last few weeks. The dairy company's shares are down over 10% from their October-high of $7.91.

Whilst I would agree that a2 Milk does look to be better value now than it did then, it does still trade at a significant premium to the market-average. At present its shares are changing hands at approximately 60x trailing earnings.

Management will provide its FY 2018 guidance next week at its annual general meeting and it will certainly have to be strong to justify this premium.

Considering the strong demand for its infant formula and the fact it has received its CFDA approval to continue selling into China next year, there is every chance that its guidance will be sufficient.

But equally it is worth remembering that should its guidance fall short of the market's expectations then its shares could come crashing down.

According to research notes I have seen, analysts are expecting earnings per share in the range of 19 to 20 New Zealand cents in FY 2018. This represents growth of between 49% and 57% year-on-year.

In my opinion, the risk/reward on offer at this point does not justify an investment and I would suggest investors hold off until its November 21 meeting. While you may miss out on a few gains if the guidance is good, you could ultimately save yourself from heavy declines if the guidance underwhelms.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »